The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.

2016-2017 cycle application now open




Supporting Investigational Research

A panel of international prestige jury members